Castle Biosciences Inc
NASDAQ:CSTL

Watchlist Manager
Castle Biosciences Inc Logo
Castle Biosciences Inc
NASDAQ:CSTL
Watchlist
Price: 30.83 USD -3.05% Market Closed
Market Cap: 855.2m USD
Have any thoughts about
Castle Biosciences Inc?
Write Note

Castle Biosciences Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Castle Biosciences Inc
Cash Equivalents Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Castle Biosciences Inc
NASDAQ:CSTL
Cash Equivalents
$95m
CAGR 3-Years
-36%
CAGR 5-Years
0%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Cash Equivalents
$1.1B
CAGR 3-Years
1%
CAGR 5-Years
-3%
CAGR 10-Years
-3%
Quest Diagnostics Inc
NYSE:DGX
Cash Equivalents
$764m
CAGR 3-Years
-8%
CAGR 5-Years
12%
CAGR 10-Years
16%
CVS Health Corp
NYSE:CVS
Cash Equivalents
$6.9B
CAGR 3-Years
-11%
CAGR 5-Years
6%
CAGR 10-Years
20%
Cigna Corp
NYSE:CI
Cash Equivalents
$5.9B
CAGR 3-Years
19%
CAGR 5-Years
5%
CAGR 10-Years
14%
Laboratory Corporation of America Holdings
NYSE:LH
Cash Equivalents
$1.5B
CAGR 3-Years
-9%
CAGR 5-Years
33%
CAGR 10-Years
10%

See Also

What is Castle Biosciences Inc's Cash Equivalents?
Cash Equivalents
95m USD

Based on the financial report for Sep 30, 2024, Castle Biosciences Inc's Cash Equivalents amounts to 95m USD.

What is Castle Biosciences Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
0%

Over the last year, the Cash Equivalents growth was 4%. The average annual Cash Equivalents growth rates for Castle Biosciences Inc have been -36% over the past three years .

Back to Top